ReNeuron Group (ReNeuron Group) Accounts Payable

: $4.53 Mil (As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

ReNeuron Group's Accounts Payable for the quarter that ended in Sep. 2023 was $4.53 Mil.

ReNeuron Group's quarterly Accounts Payable declined from Sep. 2022 ($7.08 Mil) to Mar. 2023 ($0.39 Mil) but then increased from Mar. 2023 ($0.39 Mil) to Sep. 2023 ($4.53 Mil).

ReNeuron Group's annual Accounts Payable declined from Mar. 2021 ($1.09 Mil) to Mar. 2022 ($0.97 Mil) and declined from Mar. 2022 ($0.97 Mil) to Mar. 2023 ($0.39 Mil).

ReNeuron Group Accounts Payable Historical Data

The historical data trend for ReNeuron Group's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable

3.35

3.00

1.09

0.97

0.39

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accounts Payable																9.13	0.97	7.08	0.39	4.53

ReNeuron Group Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

ReNeuron Group Accounts Payable Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (ReNeuron Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

RENE.GB:UK RENE:UK RQE1:Germany

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.